Hemotune AG
PrivateLast Round
Series B
Extension
Mar 25, 2024
Total Funding Raised
$33.54M
Company Overview
Hemotune AG is a medical devices company that develops a blood purification platform using nanoengineered magnetic beads to selectively remove harmful substances from the bloodstream.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hemotune AG Comparables
Compare Hemotune AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MediSieve | 89% | |
| ExThera Medical | 84% | |
| BOA Biomedical Inc. | 83% | |
Hemotune AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Mar 25, 2024 | ||||
| Series B Extension | Apr 26, 2022 | ||||
| Series A | Aug 12, 2020 | ||||
| Grant | Jul 9, 2020 | ||||
| Grant | Feb 1, 2020 | ||||
Accelerator | Jul 5, 2017 |
Key People
Founding team and executive leadership
Hemotune AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gebert Rüf Stiftung | Grant |
| EIT Health | Grant, Series A |
| VP Venture Partners | Series B Extension |
| EFI Lake Geneva Ventures | Series B Extension |
| Wyss Zurich | Grant |
| Belmondo Family Office | Series B Extension |
| Innosuisse | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 25, 2024
$16M round led by Belmondo Family Office
- Apr 26, 2022
$7.6M round led by OCCIDENT.
Hemotune AG Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Hemotune AG's valuation, stock price, and market status.